Back to results
US 2024/0190849 A1Published application
Aminopyrimidine compounds and methods of their use
AssigneeTyra Biosciences, Inc.
InventorsRobert L. HUDKINS, Daniel C. BENSEN
Life of this patent
Estimating the term…
Abstract
Disclosed herein are substituted aminopyrimidine compounds of formula I: and pharmaceutically acceptable salts thereof, wherein Ar, R1, and R2 have the meanings described herein; pharmaceutical compositions that include such compounds, and methods of using such compounds.
Claims32
A compound of formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- Ar is a 6-10-membered aryl group or a 5-10-membered heteroaryl group, each optionally substituted;
- R1 is H, F, Cl, Br, C1-6alkyl, CN, C1-6haloalkyl, —C(O)NH2, —C(O)NH(C1-6alkyl), or —C(O)N(C1-6alkyl)2;
- R2 is a:
- 9-membered bicyclic heteroaryl comprising a 6-5-fused ring system wherein the 5-membered ring contains at least one nitrogen atom and the 6 membered ring is substituted with at least one E;
- or
- 13-membered tricyclic heteroaryl comprising a 6-5-6-fused ring system wherein the 5-membered ring contains at least one nitrogen atom and one of the 6 membered rings is substituted with at least one E;
- or
- 12- or 13-membered tricyclic group comprising a 5- or 6-membered cycloalkyl or heterocycloalkyl ring fused to a 9-membered bicyclic heteroaryl comprising a 6-5-fused ring system wherein the 5-membered ring contains at least one nitrogen atom and the 6 membered ring is substituted with at least one E;
- wherein E is an electrophilic moiety that is capable of reacting with a nucleophile so as to form a covalent bond between an atom of the nucleophile and an atom of the electrophilic moiety.
8 more elements
-9. (canceled)
-13. (canceled)
-19. (canceled)
(canceled)
(canceled)
-40. (canceled)
-51. (canceled)
-58. (canceled)
-65. (canceled)
(canceled)
Dependencies are inferred from the claim text.